ELYM Chart
See on advanced chart >
About
Eliem Therapeutics, Inc. was incorporated on October 18, 2018 as a Delaware corporation. The Company is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain,...
Read More
- HighlightA clinical-stage biotechnology company that focused on developing novel therapies for neuronal excitability disorders
- ExchangeNASDAQ
- Listing Date08/10/2021
- Established Date10/18/2018
- Full-time Employees9
- Address23515 NE Novelty Hill Road Suite B221 #125 Redmond WA 98053
- Tel1-877-3543689
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology